Form 4: Medpace Holdings Director Brian T. Carley Acquires Stock Options

Director Brian T. Carley of Medpace Holdings, Inc. reports the acquisition of stock options exercisable for 1,224 shares of common stock.

Summary

• Brian T. Carley, a director of Medpace Holdings, Inc., filed a Form 4 disclosing changes in beneficial ownership.
• The report indicates that Carley acquired stock options on May 16, 2025, granting him the right to buy 1,224 shares of Medpace Holdings common stock at an exercise price of $305.66.
• These options vest on the earlier of the day before the first annual meeting following the grant date or the first anniversary of the grant date, contingent upon continued service on the board.
• Following the reported transaction, Carley directly owns 1,224 derivative securities (stock options) and 26,095 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of insider activity. The acquisition of options could be seen as slightly positive, indicating confidence, but it's not a strong signal.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Key Dates

Keywords

Form 4, Medpace Holdings, Brian T. Carley, stock options, beneficial ownership, director